Ipsogen is a cancer profiler that develops and markets molecular diagnostic tests designed to map diseases in order to guide patient’s and oncologist’s decision along their complex therapeutic path. Ipsogen has developed more than 60 molecular diagnostic tests which are used in the diagnosis of leukemia and on breast cancer. Molecular diagnostics, based on knowledge of the pathways involved in cancer initiation and development, now have the potential to classify the disease, measure its degree of aggressiveness and indicate which drug should preferably be used and can also be used during follow up to monitor the effectiveness of the treatment. To establish each tumor’s molecular identity, Ipsogen directly analyzes markers that signal genetic alterations at the origin of the disease, delivering unrivalled sensitivity and reliability.

Click here for Ipsogen Cancer Monitoring Kits list.


 
  company    |    products    |   services    |    news    |    contact us
  © All Rights Reserved Zelle Biotechnology Private Limited
powered by  web designers india
 
home Sitemap